- Global Pharma News & Resources

Enterome to Attend Upcoming Conferences

Enterome to Attend Upcoming Conferences


Paris, France – October 4, 2021

ENTEROME SA, a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases, today announces that Pierre Belichard, CEO, will attend and take part in 1-on-1 meetings with institutional investors at the following conferences:

•        BMO fall Life Sciences Private Company Showcase: October 14

•        Jefferies Annual IBD Next Generation Therapeutics Summit: October 19

•        Jefferies Global Healthcare Conference: November 16 -18

Editor Details

Last Updated: 06-Oct-2021